Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 7, Pages 3467
Publisher
MDPI AG
Online
2022-03-24
DOI
10.3390/ijms23073467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
- (2020) Shannon Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer
- (2020) Fionán Donohoe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ERK/MAPK signalling pathway and tumorigenesis (Review)
- (2020) Yan‑Jun Guo et al. Experimental and Therapeutic Medicine
- JNK Signaling in Stem Cell Self-Renewal and Differentiation
- (2020) Takashi Semba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of mite‐induced dermatitis, pruritus, and nerve sprouting in mice by the endothelin receptor antagonist bosentan
- (2020) Makiko Kido‐Nakahara et al. ALLERGY
- Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab
- (2020) Takeshi Nakahara et al. MEDICINE
- Atopic dermatitis endotypes and implications for targeted therapeutics
- (2019) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The prevalence and persistence of atopic dermatitis in urban United States children
- (2019) Costner McKenzie et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models
- (2019) Jean Christopher Chamcheu et al. Cells
- The role of filaggrin in atopic dermatitis and allergic disease
- (2019) Catherine Drislane et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Immunologic, microbial, and epithelial interactions in atopic dermatitis
- (2018) Patrick M. Brunner et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes
- (2018) Woo-In Ryu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The role of the OVOL1–OVOL2 axis in normal and diseased human skin
- (2018) Gaku Tsuji et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- MAPK pathway involved in epidermal terminal differentiation of normal human epidermal keratinocytes
- (2018) Xianguang Meng et al. Open Medicine
- Treatment satisfaction in atopic dermatitis relates to patient-reported severity: A cross-sectional study
- (2018) T. Nakahara et al. ALLERGY
- Research Techniques Made Simple: Transepidermal Water Loss Measurement as a Research Tool
- (2018) Helen Alexander et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines
- (2017) Hongwei Han et al. IMMUNOLOGICAL REVIEWS
- Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
- (2017) Gaku Tsuji et al. Cell Death & Disease
- Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
- (2017) Masutaka Furue et al. ALLERGOLOGY INTERNATIONAL
- Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression
- (2016) Takeshi Nakahara et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis
- (2015) M. K. Aktar et al. ALLERGY
- Regulation of ERK-MAPK signaling in human epidermis
- (2015) Joseph Cursons et al. BMC Systems Biology
- IL-33 induces Egr-1-dependent TSLP expression via the MAPK pathways in human keratinocytes
- (2015) Woo-In Ryu et al. EXPERIMENTAL DERMATOLOGY
- Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1–induced pruritus
- (2014) Makiko Kido-Nakahara et al. JOURNAL OF CLINICAL INVESTIGATION
- Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis
- (2014) Yoko Kataoka JOURNAL OF DERMATOLOGY
- Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
- (2013) Ellen H. van den Bogaard et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of IL-33 in the epidermis: The mechanism of induction by IL-17
- (2013) Jitlada Meephansan et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity
- (2013) Kenji Kabashima JOURNAL OF DERMATOLOGICAL SCIENCE
- Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice
- (2013) Yasutomo Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAP Kinase Pathways
- (2012) D. K. Morrison Cold Spring Harbor Perspectives in Biology
- Pathological roles of MAPK signaling pathways in human diseases
- (2010) Eun Kyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Tight junction defects in patients with atopic dermatitis
- (2010) Anna De Benedetto et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started